+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Rosacea Market and Competitive Landscape - 2020

  • ID: 5023435
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Rosacea Market and Competitive Landscape - 2020, provides comprehensive insights into the Rosacea pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Rosacea market size and drug sales. It also provides insights into Rosacea epidemiology and late stage pipeline.

This research covers the following: Rosacea treatment options, Rosacea late stage clinical trials pipeline, Rosacea prevalence by countries, Rosacea market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Rosacea pipeline: Find out drugs in clinical trials for the treatment of Rosacea by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Rosacea epidemiology: Find out the number of patients diagnosed (prevalence) with Rosacea by countries
  • Rosacea drugs: Identify key drugs marketed and prescribed for Rosacea in the US, including trade name, molecule name, and company
  • Rosacea drugs sales: Find out the sales value for Rosacea drugs by countries
  • Rosacea market valuations: Find out the market size for Rosacea drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Rosacea drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Rosacea drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Rosacea market
  • Develop in-depth knowledge of competition and markets
  • Analyze Rosacea drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Rosacea market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Rosacea Treatment Options

2. Rosacea Pipeline Insights
2.1. Rosacea Phase 3 Clinical Trials
2.2. Rosacea Phase 2 Clinical Trials
2.3. Rosacea Phase 1 Clinical Trials

3. Rosacea Epidemiology Analysis by Countries

4. Germany Rosacea Market Insights
4.1. Marketed Drugs for Rosacea in Germany
4.2. Germany Rosacea Market Size & Forecast
4.3. Germany Rosacea Drugs Sales Forecast
4.4. Germany Rosacea Market Share Analysis

5. France Rosacea Market Insights
5.1. Marketed Drugs for Rosacea in France
5.2. France Rosacea Market Size & Forecast
5.3. France Rosacea Product Sales Forecast
5.4. France Rosacea Market Share Analysis

6. Italy Rosacea Market Insights
6.1. Marketed Drugs for Rosacea in Italy
6.2. Italy Rosacea Market Size & Forecast
6.3. Italy Rosacea Product Sales Forecast
6.4. Italy Rosacea Market Share Analysis

7. Spain Rosacea Market Insights
7.1. Marketed Drugs for Rosacea in Spain
7.2. Spain Rosacea Market Size & Forecast
7.3. Spain Rosacea Product Sales Forecast
7.4. Spain Rosacea Market Share Analysis

8. UK Rosacea Market Insights
8.1. Marketed Drugs for Rosacea in UK
8.2. UK Rosacea Market Size & Forecast
8.3. UK Rosacea Product Sales Forecast
8.4. UK Rosacea Market Share Analysis

9. Europe Rosacea Market Insights
9.1. Europe Rosacea Market Size & Forecast
9.2. Europe Rosacea Product Sales Forecast
9.3. Europe Rosacea Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Rosacea Phase 3 Clinical Trials, Global, 2020
Table 2: Rosacea Phase 2 Clinical Trials, Global, 2020
Table 3: Rosacea Phase 1 Clinical Trials, Global, 2020
Table 4: Rosacea Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Rosacea in Germany, 2019
Table 6: Germany Rosacea Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Rosacea Product Sales ($mn), 2016 - 2024
Table 8: Germany Rosacea Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Rosacea in France, 2019
Table 10: France Rosacea Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Rosacea Product Sales ($mn), 2016 - 2024
Table 12: France Rosacea Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Rosacea in Italy, 2019
Table 14: Italy Rosacea Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Rosacea Product Sales ($mn), 2016 - 2024
Table 16: Italy Rosacea Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Rosacea in Spain, 2019
Table 18: Spain Rosacea Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Rosacea Product Sales ($mn), 2016 - 2024
Table 20: Spain Rosacea Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Rosacea in UK, 2019
Table 22: UK Rosacea Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Rosacea Product Sales ($mn), 2016 - 2024
Table 24: UK Rosacea Market Events and Trends, 2016 - 2024
Table 25: Europe Rosacea Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Rosacea Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Rosacea Pipeline by Phase (%), Global, 2020
Figure 2: Rosacea Prevalence by Countries, 2016 - 2024
Figure 3: Germany Rosacea Market Size ($mn), 2016 - 2024
Figure 4: Germany Rosacea Product Sales ($mn), 2016 - 2024
Figure 5: Germany Rosacea Market Share by Drugs (%), 2019
Figure 6: Germany Rosacea Market - Future Market Share (%), 2024
Figure 7: France Rosacea Market Size ($mn), 2016 - 2024
Figure 8: France Rosacea Product Sales ($mn), 2016 - 2024
Figure 9: France Rosacea Market Share by Drugs (%), 2019
Figure 10: France Rosacea Market - Future Market Share (%), 2024
Figure 11: Italy Rosacea Market Size ($mn), 2016 - 2024
Figure 12: Italy Rosacea Product Sales ($mn), 2016 - 2024
Figure 13: Italy Rosacea Market Share by Drugs (%), 2019
Figure 14: Italy Rosacea Market - Future Market Share (%), 2024
Figure 15: Spain Rosacea Market Size ($mn), 2016 - 2024
Figure 16: Spain Rosacea Product Sales ($mn), 2016 - 2024
Figure 17: Spain Rosacea Market Share by Drugs (%), 2019
Figure 18: Spain Rosacea Market - Future Market Share (%), 2024
Figure 19: UK Rosacea Market Size ($mn), 2016 - 2024
Figure 20: UK Rosacea Product Sales ($mn), 2016 - 2024
Figure 21: UK Rosacea Market Share by Drugs (%), 2019
Figure 22: UK Rosacea Market - Future Market Share (%), 2024
Figure 23: Europe Rosacea Market Size ($mn), 2016 - 2024
Figure 24: Europe Rosacea Product Sales ($mn), 2016 - 2024
Figure 25: Europe Rosacea Market Share by Drugs (%), 2019
Figure 26: Europe Rosacea Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll